1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow ALK-Positive Anaplastic Large Cell Lymphoma: new trials by email Literature Review of ALK-Positive Anaplastic Large Cell Lymphoma trials Research Report on ALK-Positive Anaplastic Large Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Crizotinib Combined With Etoposide Capsule Followed by Auto-HSCT for Relapsed and Refractory ALK+ ALCL Crizotinib, Etoposide Capsule, Auto-HSCT - ALK-Positive Anaplastic Large Cell Lymphoma | Phase 4 | Unknown | Mingzhi Zhang | 20 | 2018-10-01 | 2018-10-16 |
Crizotinib (1) · Etoposide (1)
Mingzhi Zhang (1)
China (1)